US Patent Issued to Hoffmann-La Roche on May 26 for "Fc-receptor binding modified asymmetric antibodies and methods of use" (German Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,506, issued on May 26, was assigned to Hoffmann-La Roche Inc.. "Fc-receptor binding modified asymmetric antibodies and methods of use" was i... Read More

US Patent Issued to UCB BIOPHARMA on May 26 for "Antibody with binding specificity for human IL-13" (British Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,507, issued on May 26, was assigned to UCB BIOPHARMA SRL (Brussels). "Antibody with binding specificity for human IL-13" was invented by Dan... Read More

US Patent Issued to Eli Lilly and Co. on May 26 for "Antibodies that bind human and mouse INSL5 and encoding nucleic acids thereof" (American, Danish Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,508, issued on May 26, was assigned to Eli Lilly and Co. (Indianapolis). "Antibodies that bind human and mouse INSL5 and encoding nucleic ac... Read More

US Patent Issued to Janssen Biotech on May 26 for "Trispecific antibody targeting BCMA, GPRC5D, and CD3" (American, Belgian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,509, issued on May 26, was assigned to Janssen Biotech Inc. (Horsham, Pa.). "Trispecific antibody targeting BCMA, GPRC5D, and CD3" was inven... Read More

US Patent Issued to CITY OF HOPE on May 26 for "Oncolytic virus compositions and methods for the treatment of cancer" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,510, issued on May 26, was assigned to CITY OF HOPE (Duarte, Calif.). "Oncolytic virus compositions and methods for the treatment of cancer"... Read More

US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on May 26 for "Methods for expansion of tumor infiltrating lymphocytes and use thereof" (Texas Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,511, issued on May 26, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas). "Methods for expansion of tumor inf... Read More

US Patent Issued to REGENECORE BIOTECH on May 26 for "Humanized anti-il-4RAlpha single domain antibody and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,512, issued on May 26, was assigned to REGENECORE BIOTECH Co. LTD (Jiangsu, China). "Humanized anti-il-4RAlpha single domain antibody and ap... Read More

US Patent Issued to ImmunEdge, The Board of Trustees of the Leland Stanford Junior University on May 26 for "Method of treating cancer by administering an inhibitor of erythropoietin receptor activity comprising either erythropoietin receptor or erythropoietin protein" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,513, issued on May 26, was assigned to ImmunEdge Inc. (Redwood City, Calif.) and The Board of Trustees of the Leland Stanford Junior Universi... Read More

US Patent Issued to ImmunEdge, The Board of Trustees of the Leland Stanford University on May 26 for "Antibodies that inhibit erythropoietin receptor activation and methods of use thereof to treat cancer" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,514, issued on May 26, was assigned to ImmunEdge Inc. (Redwood City, Calif.) and The Board of Trustees of the Leland Stanford University (Sta... Read More

US Patent Issued to GENMAB on May 26 for "Binding agents binding to PD-L1 and CD137 and use thereof" (Dutch, German Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,515, issued on May 26, was assigned to GENMAB A/S (Valby, Denmark). "Binding agents binding to PD-L1 and CD137 and use thereof" was invented... Read More

• ««
• «
• 79132
• 79133
• 79134
• 79135
• 79136
• 79137
• 79138
• 79139
• 79140
• 79141
• »
• »»